Regulatory section - SEMPER

Find the original column of Semper Luxembourg in collaboration with the Division de la Pharmacie et des Médicaments (DPM) on subjects concerning the regulation in Luxembourg.
Impact réglementaire de l'essor des Applications Digitales de Santé
Retour d'expérience et nouvelles questions suscitées par l'usage du cannabis médicinal
202209 - Regulatory applicable to medicines in innovative therapy
202207 - Covid19 impact on european medicines regulations
202206 - Réglement européen sur les médicaments vétérinaires
Enter into force of european regulation on clinical trials with medicines for human use
COVID19, Balance sheet on medicines after two years of pandemic
From DPM to a real Agency for Medicines and Health Products
Cannabis, what one should know
Life cycle of a medicine
Compassionate use of medicinal drugs
COVID19 Research and Access
Guided tour to RCP (part 4)
Guided tour to RCP (part 3)
Guided tour to RCP (part 2)
Valuation of Quality, Safety and Efficiency of Medicines (part 3)
Guided tour to RCP (part 1)
Valuation of Quality, Safety and Efficiency of Medicines (part 2)
Valuation of Quality, Safety and Efficiency of Medicines (part 1)
COVID19 Pharmacovigilance
COVID19 Antibodies
COVID vaccines, what one should know
Unavailability and Shortage
COVID19 The point on vaccines
Become a member

Keep up to date with

The flash letter informs you regularlay about the news of our sector in Luxembourg, the news of the research in Luxembourg, within our members and finally about the news of the association.  Don't waste a minute and subscribe.